Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
- 8 October 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Meta‐Analysis: Enhanced Liver Fibrosis ( ELF ) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction‐Associated Steatotic Liver DiseaseAlimentary Pharmacology & Therapeutics, 2026
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver diseaseHepatology, 2023